SCHEMBL23198512

SCHEMBL23198512

C=C(Cl)/N=C(C)\C(C=N)=C(/C)Nc1cccc(OC(F)(F)F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX1 P51575 1/20 0.40
NPY5R Q15761 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
EPHX2 P34913 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
HTT P42858 1/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
EGFR P00533 2/20 0.36
ITK Q08881 2/20 0.36
SLC22A12 Q96S37 1/20 0.35
PDK1 Q15118 1/20 0.34
PDK2 Q15119 1/20 0.34
PDK3 Q15120 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23197819 0.79 MEN1 (0.33)
SCHEMBL13170081 0.68 L3MBTL1 (0.64) P2RX1NPC1RAB9AEPHX2ALDH1A1
SCHEMBL23197769 0.68 TP53 (0.49) RAB9AALDH1A1GAAMAPTHTT
SCHEMBL18732586 0.66 NPC1 (0.49) P2RX1NPY5RNPC1RAB9AEPHX2
SCHEMBL14126108 0.66 NPC1 (0.51) P2RX1NPY5RNPC1RAB9AEPHX2
SCHEMBL23197815 0.66 LMNA (0.41) RAB9AEPHX2ALDH1A1GAAMAPT
SCHEMBL10310240 0.66 ALDH1A1 (0.52) P2RX1NPC1RAB9AEPHX2ALDH1A1
SCHEMBL23198944 0.65 TP53 (0.46) RAB9AALDH1A1GAAMAPTHTT
SCHEMBL14126110 0.65 HTR3E (0.55) P2RX1NPC1RAB9AEPHX2ALDH1A1
SCHEMBL30684939 0.65 EGFR (0.65) P2RX1NPC1RAB9AEPHX2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021064077-A1 SUBSTITUTED PYRAZOLOPYRIMIDINES AS IRAK4 INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2021-04-08 WO disclosed